REDWOOD CITY, Calif., June 16, 2008 (PRIME NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (THLD) today announced that it has received approval from the NASDAQ Listing Qualifications Panel (the Panel) to transfer the listing of its common stock from The NASDAQ Global Market to The NASDAQ Capital Market. The transfer will be effective as of the opening of trading on June 17, 2008. The Company will continue to trade under the symbol “THLD.”
